Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Graves' Disease in Hypopituitarism Due to Pituitary Apoplexy.
Mura C, Sonnino R, Crispino L, Rota CA, Pontecorvi A. Mura C, et al. Among authors: pontecorvi a. Endocr Metab Immune Disord Drug Targets. 2024 Jul 11. doi: 10.2174/0118715303322830240528051609. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38994610
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues.
Raia S, Chiloiro S, Giampietro A, Maratta MG, Attili F, Brizi MG, Rufini V, De Marinis L, Pontecorvi A, Rindi G, Schinzari G, Bianchi A. Raia S, et al. Among authors: pontecorvi a. Endocr Metab Immune Disord Drug Targets. 2024;24(12):1464-1469. doi: 10.2174/0118715303277049231229051823. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38284724
The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LAR.
Costanza F, Chiloiro S, Giampietro A, Angelini F, Infante A, Pontecorvi A, De Marinis L, Bianchi A. Costanza F, et al. Among authors: pontecorvi a. Endocr Metab Immune Disord Drug Targets. 2024 Jul 5. doi: 10.2174/0118715303322301240610111946. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38982703
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition.
Costanza F, Cicia M, Giampietro A, Tartaglione T, Angelini F, Zoli A, Ferrazzani S, De Marinis L, Pontecorvi A, Bianchi A, Chiloiro S. Costanza F, et al. Among authors: pontecorvi a. Endocr Metab Immune Disord Drug Targets. 2024 Jul 30. doi: 10.2174/0118715303314953240719044233. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 39082174
The Differential Diagnosis between Cushing's Disease and Pseudocushing Syndrome in a Pre-agonic Patient.
De Sanctis SA, Chiloiro S, Tanzarella ES, Bongiovanni F, Giampietro A, De Pascale G, De Marinis L, Antonelli M, Pontecorvi A, Bianchi A. De Sanctis SA, et al. Among authors: pontecorvi a. Endocr Metab Immune Disord Drug Targets. 2024 Jul 30. doi: 10.2174/0118715303322978240725061753. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 39082178
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy.
Chiloiro S, Vicari A, Mongelli G, Costanza F, Giampietro A, Mattogno PP, Lauretti L, Olivi A, De Marinis L, Doglietto F, Bianchi A, Pontecorvi A. Chiloiro S, et al. Among authors: pontecorvi a. Rev Endocr Metab Disord. 2024 Oct;25(5):855-873. doi: 10.1007/s11154-024-09898-6. Epub 2024 Aug 22. Rev Endocr Metab Disord. 2024. PMID: 39168952 Free PMC article. Review.
465 results